M&A Deal Summary

Bain Capital Private Equity Acquires Mitsubishi Tanabe Pharma

On February 7, 2025, private equity firm Bain Capital Private Equity acquired life science company Mitsubishi Tanabe Pharma from Mitsubishi Chemical for 3.3B USD

Acquisition Highlights
  • This is Bain Capital Private Equity’s 12th transaction in the Life Science sector.
  • This is Bain Capital Private Equity’s 16th largest (disclosed) transaction.
  • This is Bain Capital Private Equity’s 15th transaction in Japan.

M&A Deal Summary

Date 2025-02-07
Target Mitsubishi Tanabe Pharma
Sector Life Science
Buyer(s) Bain Capital Private Equity
Sellers(s) Mitsubishi Chemical
Deal Type Divestiture
Deal Value 3.3B USD

Target

Mitsubishi Tanabe Pharma

Osaka, Japan
Mitsubishi Tanabe Pharma is a research-driven pharmaceutical company that specializes in the research, development, and marketing of globally competitive pharmaceutical products focused on the field of autoimmune disease, diabetes and kidney disease, and CNS disease. Mitsubishi Tanabe Pharma was founded in 1933 and is based in Osaka, Japan.

Search 205,905 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bain Capital Private Equity

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1984
PE ASSETS 44.2B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Bain Capital Private Equity (BCPE), is the private equity investment arm of alternative asset management firm, Bain Capital. BCPE targets leveraged buyout and growth capital transactions in a wide variety of industries including information technology, communications, media, healthcare, industrial/manufacturing, retail/consumer, and financial services. Bain Capital is based in Boston with additional offices in New York, London, Mumbai, Hong Kong, Shanghai, Tokyo, and Munich.


DEAL STATS #
Overall 243 of 247
Sector (Life Science) 12 of 12
Type (Divestiture) 39 of 39
Country (Japan) 15 of 15
Year (2025) 4 of 8
Size (of disclosed) 16 of 74
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-05 Milacron

Cincinnati, Ohio, United States

Milacron provides plastics processing equipment, technologies, and services. It offers hot runner systems, temperature controllers, and auxiliary equipment; and mold bases, mold components, cold runner systems, and control systems for the plastics industry. Milacron was founded in 2000 and is based in Cincinnati, Ohio.

Buy $287M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-14 Apleona

Neu-Isenburg, Germany

Apleona is a real estate services provider, that operates, manage, expand and equip real estate in all asset classes, operate and maintain plant and assist customers in a whole host of industries with production and secondary processes. The Group's range of services extends from integrated facility management, building technology, and interior fittings to real-estate management with all commercial services, letting and leasing of real estate. All services are provided on a modular basis or in an integrated package. Apleona was founded in 2016 and is based in Neu-Isenburg, Germany.

Buy -

Seller(S) 1

SELLER

Mitsubishi Chemical

Tokyo, Japan

Category Company
Founded 2005
Sector Chemicals
Employees66,358
Revenue 4.39T JPY (2024)
DESCRIPTION

Mitsubishi Chemical provides chemistry-based technology platforms for the development of a wide range of technologies and products in the fields of performance products, healthcare, and industrial materials. Mitsubishi Chemical was founded in 2005 and is based in Tokyo, Japan.


DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 2 of 2
Country (Japan) 2 of 2
Year (2025) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-18 Mitsubishi Tanabe Pharma

Osaka, Japan

Mitsubishi Tanabe Pharma is a research-driven pharmaceutical company that specializes in the research, development, and marketing of globally competitive pharmaceutical products focused on the field of autoimmune disease, diabetes and kidney disease, and CNS disease. Mitsubishi Tanabe Pharma was founded in 1933 and is based in Osaka, Japan.

Buy -